This next-generation bivalent COVID-19 vaccine candidate, BNT162b5, consists of RNAs encoding enhanced prefusion spike proteins for the SARS-CoV-2 ancestral strain (wild-type) and an Omicron variant.
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Dr Sai Satish, Sr. Consultant Interventional Cardiologist performs India’s first 3 successful G4-Transcatheter Edge to Edge (G4–TEER) mitral valve repairs
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
Completion of the demerger of Haleon and share consolidation of GSK
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
Subscribe To Our Newsletter & Stay Updated
